Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits-Reference-Cited by-同舟云学术

Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits

Published:2020-12-15 Issue:3 Volume:37 Page:18-33
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Gorbet Michael-Joseph¹,Singh Akansha¹,Mao Chenkai²,Fiering Steven²³,Ranjan Ashish¹

Affiliation:

1. College of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA

2. Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA

3. Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Norris Cotton Cancer Center at Dartmouth and Dartmouth Hitchcock, Lebanon, NH, USA

Funder

National Cancer Institute of the National Institutes of Health

seed grant from the OSU Center for Veterinary Health Sciences

the Focused Ultrasound Foundation

PETCO and the Kerr

McCasland Foundation

Norris Cotton Cancer Center at Dartmouth

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2020.1802519

Reference160 articles.

1. NFAT1 Supports Tumor-induced Anergy of CD4+ T Cells

2. Immunosuppressive Strategies that are Mediated by Tumor Cells

3. PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy

4. Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies

5. Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing in situ cancer vaccines using delivery technologies;Nature Reviews Drug Discovery;2024-07-01

2. Age-associated changes in the gut microbiome impact efficacy of tumor immunomodulatory treatments;Experimental Gerontology;2023-10

3. Overcoming Resistance to Immune Checkpoint Inhibitor Therapy Using Calreticulin-Inducing Nanoparticle;Pharmaceutics;2023-06-09

4. Implantable smart hyperthermia nanofibers for cancer therapy: Challenges and opportunities;WIREs Nanomedicine and Nanobiotechnology;2023-05-31

5. Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors;Frontiers in Pharmacology;2023-04-26